| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/1352458512457845 |
| P698 | PubMed publication ID | 23012252 |
| P2093 | author name string | Kai Wang | |
| Wei Qiu | |||
| Xueqiang Hu | |||
| Honghao Wang | |||
| Xiaonan Zhong | |||
| Conghui Wang | |||
| P2860 | cites work | Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria | Q24605493 |
| Neuromyelitis optica and asian phenotype of multiple sclerosis | Q28300078 | ||
| High plasma level of long pentraxin 3 (PTX3) is associated with fatal disease in bacteremic patients: a prospective cohort study | Q31004218 | ||
| The proteomic analysis of mouse choroid plexus secretome reveals a high protein secretion capacity of choroidal epithelial cells | Q33260881 | ||
| A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica | Q33727402 | ||
| Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study | Q34150807 | ||
| Vascular aspects of multiple sclerosis. | Q34193600 | ||
| Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction | Q34357988 | ||
| Characterization of the promoter for the human long pentraxin PTX3. Role of NF-kappaB in tumor necrosis factor-alpha and interleukin-1beta regulation | Q34420055 | ||
| Revised diagnostic criteria for neuromyelitis optica | Q34529345 | ||
| Pentraxins in innate immunity: from C-reactive protein to the long pentraxin PTX3. | Q34683473 | ||
| The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps | Q36229261 | ||
| The long pentraxin PTX3 in vascular pathology | Q36615475 | ||
| The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines | Q36946338 | ||
| Mechanisms of inflammation induced tissue injury in multiple sclerosis | Q37169869 | ||
| The long pentraxin PTX3 as a prototypic humoral pattern recognition receptor: interplay with cellular innate immunity | Q37361426 | ||
| EFNS guidelines on diagnosis and management of neuromyelitis optica | Q37763266 | ||
| AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance | Q37773790 | ||
| Pentraxins: CRP and PTX3 and cardiovascular disease | Q37871613 | ||
| Long pentraxin 3 (PTX3) in the light of its structure, mechanism of action and clinical implications | Q37944361 | ||
| Pathology of demyelinating diseases | Q37982130 | ||
| Living kidney donation: anemia and inflammation in the early postoperative period | Q42684373 | ||
| Structural characterization of PTX3 disulfide bond network and its multimeric status in cumulus matrix organization | Q46788898 | ||
| Increases of pentraxin 3 plasma levels in patients with Parkinson's disease | Q48875364 | ||
| Cerebrospinal fluid pentraxin 3 early after subarachnoid hemorrhage is associated with vasospasm. | Q53985364 | ||
| Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA) | Q56943278 | ||
| P433 | issue | 7 | |
| P921 | main subject | multiple sclerosis | Q8277 |
| P304 | page(s) | 926-931 | |
| P577 | publication date | 2012-09-25 | |
| P1433 | published in | Multiple Sclerosis Journal | Q1952449 |
| P1476 | title | Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica | |
| P478 | volume | 19 |
| Q36263536 | Acute Phase Proteins in Cerebrospinal Fluid from Dogs with Naturally-Occurring Spinal Cord Injury |
| Q34996129 | Comparison of clinical characteristics between neuromyelitis optica spectrum disorders with and without spinal cord atrophy |
| Q30235347 | Headache in Neuromyelitis Optica |
| Q34999439 | Inflammation markers in multiple sclerosis: CXCL16 reflects and may also predict disease activity |
| Q89687402 | Is pentraxin 3 level an effective biomarker in disease activity in patients with rheumatoid arthritis? |
| Q39160620 | Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patients with systemic sclerosis. |
| Q40313198 | Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease |
| Q39632598 | Sucrose non-fermenting AMPK related kinase/Pentraxin 3 and DNA damage axis: a gateway to cardiovascular disease in systemic lupus erythematosus among Egyptian patients |
| Q35692264 | Systemic and Ocular Long Pentraxin 3 in Patients with Age-Related Macular Degeneration |
| Q89099512 | The Relationship Between Serum Pentraxine 3 Levels and Hematological Markers in Patients With Rheumatoid Arthritis |
| Q37565386 | Transcriptome sequencing of neurologic diseases associated genes in HHV-6A infected human astrocyte |
| Q47626900 | Update on the role of Pentraxin 3 in atherosclerosis and cardiovascular diseases |
Search more.